Changzhou Institute of Materia Medica (CIMM) established as a provincial research institution.
About Beatrice
Four Decades of Hyaluronic Acid Science.
From China's pioneering HA research institution to a global aesthetics partner.
Beatrice is the medical aesthetics brand of Changzhou Institute of Materia Medica Co., Ltd. (CIMM), backed by over 40 years of expertise in hyaluronic acid research and manufacturing. Originating from surgical anti-adhesion and ophthalmic materials, we transitioned into the medical aesthetics sector in 2013.
Verified through clinical practice.
Today, Beatrice stands as a professional medical aesthetics brand, supported by CIMM’s integrated R&D, manufacturing, and clinical validation capabilities. We provide global distributors and clinics with high-quality hyaluronic acid fillers, skin boosters, and PDLLA regenerative products — ensuring quality from the source and verified results through clinical practice.
Looking ahead, we are committed to expanding our product boundaries in regenerative aesthetics and skin rejuvenation, while deepening our global partnerships.
From Provincial Institute to Global Partner.
Became the first domestic developer and manufacturer of medical-grade sodium hyaluronate raw materials and formulations.
Established a strategic partnership with the NMI Institute at the University of Tübingen, Germany.
Launched the medical aesthetics brand, Beatrice.
Initiated global regulatory registrations for medical aesthetic products and commenced sales in Southeast Asia.
Completing the global registration portfolio (CE, MDSAP) and further expanding sales channels.
In ProgressEmpowering Aesthetic Renewal Through Science.
Medical aesthetics is more than cosmetic enhancement — it is about elevating the quality of life. We build our foundation on rigorous medical standards.
Improving health and making life more beautiful.
We bring the precision of serious medicine and clinical-grade science into every product we develop.
A trusted global partner in regenerative medicine.
We aim to be the partner doctors and clinics rely on worldwide, through continuous innovation.
Patient-Centric
Clinical safety and patient satisfaction are our ultimate benchmarks.
Quality First
Adhering to clinical-grade standards; every batch is rigorously tested.
Scientific Innovation
Evidence-based development, and growth alongside our partners.
Integrity & Compliance
Upholding global regulations to ensure transparent and reliable partnerships.
From Breakthroughs to Precision Tools.
By integrating the rigorous logic of biopharmaceuticals into our entire workflow, we transform scientific breakthroughs into precision tools for clinicians.
Building a Technological Moat
Expert Leadership
CIMM’s R&D team is led by PhDs and industry professors, spanning cell biology, synthetic biology, and materials science.
Technical Depth
Including 53 invention patents, with 14 core technologies in HA molecular modification and cross-linking.
International Synergy
Deep collaboration with the NMI Institute at the University of Tübingen keeps our technology at the global forefront.
A Medical Device Quality Loop
Comprehensive Control
CIMM’s modern R&D and testing center manages every step from raw material intake to finished product release under GMP.
Full-Inspection Strategy
Beyond supplier reports, we re-test over 30 key indicators for every batch of raw materials.
Clinical Closed-Loop
Products are validated in our own clinic before market — an R&D-to-Production-to-Clinical loop that keeps results safe and reliable.
Let's partner for the long term.
We provide global distributors and clinics with high-quality hyaluronic acid fillers, skin boosters, and PDLLA regenerative products — quality from the source, verified results through clinical practice.
- Request samples or full technical documentation
- Discuss distribution and registration in your market
- Schedule a clinical consultation or facility visit
40 years of science. A partnership for the future.
Request Your Evaluation Kit →


